Home » Topics » Disease categories and therapies » Immune

Immune
RSS

BMS presents new IMP dehydrogenase inhibitors

June 13, 2000

VX-497: in vitro and in vivo findings on a selective, orally active IMPDH inhibitor

June 13, 2000

Health Canada grants priority review to Prevnar

June 13, 2000

ICN-10776 reported at Immunology 2000 to induce Th2 cytokine bias

June 9, 2000

Roche scientists disclose new series of protein kinase inhibitors and their use

June 8, 2000

Selective EP2-binding agents and their therapeutic use claimed by Ono

June 8, 2000

Vical's cationic lipid formulation selectively enhances antibody immune response to antigen pDNA

June 7, 2000

Intellivax and Active Biotech form partnership to develop streptococcal vaccine

June 7, 2000

Efforts to develop malaria vaccines reviewed at ECCMID; new candidate from SB highlighted

June 2, 2000

Repligen acquires U.S. patent rights to CTLA4-Ig

June 2, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...